» Articles » PMID: 20067763

MiR-150 Promotes Gastric Cancer Proliferation by Negatively Regulating the Pro-apoptotic Gene EGR2

Overview
Publisher Elsevier
Specialty Biochemistry
Date 2010 Jan 14
PMID 20067763
Citations 120
Authors
Affiliations
Soon will be listed here.
Abstract

Accumulating evidence suggests small non-coding RNAs (microRNAs) play important roles in human cancer progression. In the present study, we found miR-150 was overexpressed in gastric cancer cell lines and tissues. Ectopic expression of miR-150 promoted tumorigenesis and proliferation of gastric cancer cells. Luciferase reporter assay demonstrated that EGR2 was a direct target of miR-150. Collectively, our study demonstrated that overexpression of miR-150 in gastric cancer could promote proliferation and growth of cancer cells at least partially through directly targeting the tumor-suppressor EGR2, suggesting a potential strategy for the development of miRNA-based treatment of gastric cancer.

Citing Articles

Exosomal miR-151-3p in saliva: A potential non-invasive marker for gastric cancer diagnosis and prognosis modulated by Sijunzi decoction (SJZD) in mice.

Yang P, Lei H, Fu Y, Chen C, Tang L, Xia S Heliyon. 2024; 10(7):e29169.

PMID: 38633631 PMC: 11021977. DOI: 10.1016/j.heliyon.2024.e29169.


Non-coding RNA transcripts, incredible modulators of cisplatin chemo-resistance in bladder cancer through operating a broad spectrum of cellular processes and signaling mechanism.

Hashem M, Khosroshahi E, Aliahmady M, Ghanei M, Rezaie Y, Jafari Y Noncoding RNA Res. 2024; 9(2):560-582.

PMID: 38515791 PMC: 10955558. DOI: 10.1016/j.ncrna.2024.01.009.


Palbociclib suppresses the cancer stem cell properties and cell proliferation through increased levels of miR-506 or miR-150 in Panc-1 and MiaPaCa-2 cells.

Rencuzogullari O, Arisan E Turk J Biol. 2023; 46(5):342-360.

PMID: 37529006 PMC: 10387936. DOI: 10.55730/1300-0152.2622.


Multiple functions and regulatory network of miR-150 in B lymphocyte-related diseases.

Hu Y, Li Q, Wang P, Li X, Hu Z Front Oncol. 2023; 13:1140813.

PMID: 37182123 PMC: 10172652. DOI: 10.3389/fonc.2023.1140813.


Biosensing chips for cancer diagnosis and treatment: a new wave towards clinical innovation.

Iqbal M, Javed Z, Herrera-Bravo J, Sadia H, Anum F, Raza S Cancer Cell Int. 2022; 22(1):354.

PMID: 36376956 PMC: 9664821. DOI: 10.1186/s12935-022-02777-7.